We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

September 6, 2018

A Beginners Guide to the Anatomy of Blockchain In Healthcare

Commentary
Hanna Phelan
&
The entire human genome is thought to be about 200 gigabytes (GB) - for reference, 10GB would be about 900 Encyclopedia Britannica volumes. As we progress into a new health paradigm of personalisation and prevention we are being forced to consider how we can make growing masses of data, like genomic data, more accessible for consumers, ensure privacy and facilitate interoperability. Enter Blockchain. Blockchain has been making its way into the Healthcare lexicon as a potential facilitator to help us address these mammoth goals. In this weeks blog we break down the opportunities and realities of Blockchain in Healthcare to help provide a foothold in this emerging environment.

It will comes as no surprise that our data is held in fragmented silos, from EHRs to wearables. Blockchain came to our attention due to the cryptocurrency overhype, but there is real hope and scientific validation behind the technology beyond this application. At its core, Blockchain in healthcare is positioned as bringing together these silos of data and empowering the consumer to access, store, share and use their data like never before. Even more broadly speaking, Blockchain and smart contracts represent new opportunities for augmented reimbursement and a further move towards a system truly embedded in the value based care. However, as with all digital health interventions, it is clear Blockchain alone is not the answer to these macro healthcare issues.

Blockchain applcations in healthcare

First, some Blockchain misconceptions:

Blockchain is said to have been established in 1991 by a group of researchers looking for a simple way to timestamp digital documents. This iteration of Blockchain went by largely unused until it was adapted by the elusive alias ‘Satoshi Nakamoto’ in 2008 in order to serve as the public transaction ledger of the cryptocurrency Bitcoin. Since then interest has skyrocketed in terms of Blockchain's potential in all fields including humanitarian aid, FinTech and healthcare. However a number of misconceptions have emerged and infiltrated the public dialogue, misconceptions that are important to clarify as we look to understand the emerging application of Blockchain in Healthcare.

Here are some Blockchain truths to set the scene:

  1. Your data does not go on the Blockchain - depending on the way it is built, your data may or may not exist on the chain (blockchain can store full or partial data).
  2. We do not know what the future of Blockchain in Healthcare really looks like - there are a number of early stage pilots, a handful of Initial Coin Offering (ICOs) and a growing body of Healthcare Blockchain startups but to date a well established precedent has not been set
  3. Blockchain is not guaranteed to be entirely secure - Blockchain is one of the most secure technologies of our time but as any other system it has its flaws
  4. Blockchain is a type of technology, not a single network, or application, or a data analytics tool

So, what exactly is Blockchain and what benefit could it offer in healthcare?

At its most basic level Blockchain is a transactional ledger recording the movement of transactions from one party to another. Blockchain is unique as it is a distributed ledger made up of a network of partners, or peers, sharing a single copy of the ledger.

Three key characteristics of Blockchain Technology:

These characteristics make Blockchain tamper proof and highly resilient which is ideal for the the assurance of integrity, that we are increasingly requiring with mounting data sets such as those building in Healthcare today.

Types of blockchain

Blockchain technology can be applied to a number of sectors and implemented in many different ways including public, private and hybrid. These hybrid models may be particularly interesting in the Healthcare context for example, with some segments of data being privately held by the consumer and select portions being publicly readable, and allowing appropriate levels of access for relevant stakeholders.

With this in mind two applications in healthcare appear to be an appropriate fit with the promise offered by Blockchain technology - Electronic Medical Records (EMRs) and Payments.

EMRs are currently maintained in centralized data centers, single point of failure, expensive to maintain, with access limited to hospital and care provider networks. With Blockchain enabled reform could store the complete medical history for each patient, with multiple levels of control by the patient, doctors, regulators, hospitals, insurers etc. providing a secure mechanism to record and maintain comprehensive medical histories for every patient.

In relation to pre authorised payments claims are often submitted without all required documentation and details. As a result, payers need to request additional detail, which adds costs and delays to the settlement process. Blockchain could help us simplify this, automating the collection and sharing of information and allowing claims to be reviewed and paid more efficiently and quickly.

Where is Blockchain being applied in Healthcare today?

There are a multitude of avenues being explored by startups in this space, with varied levels of success, from supply chain optimization to empowered PHRs. Initial coin offerings (ICOs) facilitate companies to work on their project is like a kickstarter project - this is where we will potentially see the early wins in Healthcare Blockchain but inevitably a number of challenges and failures. There have been about 38 ICOs in Healthcare Blockchain to date for example that of DocAi who launched their token sale, $NRN (Neuron), successfully in 2017 allowing consumers to participate in data trials, earn financial compensations by training their own AI, and receive personalized health insights.

Market Landscape of organizations working with blockchain in healthcare today

MIT and Beth Israel Medical Center: One  collaboration worth noting is between MIT, their spin-out MedRec and the Beth Israel Medical Center. This group launched a pilot in Beth Israel based on the Ethereum system of Smart Contracts. In this White Paper MedRec the team highlights that the prototype provides a proof-of-concept system, demonstrating how principles of decentralization and blockchain architectures could contribute to secure, interoperable EHR systems.

NHS and Google Deepmind: One other healthsystem example worth noting is that of the NHS and Google Deepmind who announced a collaboration last year to develop an auditing system for healthcare based around blockchain technology, within a closed network of participants, to create robust audit trails that track exactly what happens to personal data. The goal is to enable the NHS—and eventually patients—to track personal data access and use in real time.

Mayo Clinic and Medical Chain entered into a pilot programme with MedicalChain in June 2018 to explore several use cases using blockchain based electronic health records. Like so many of these partnerships, this pilot is early stage and the finer details have not been generally released, however moves by lending institutions such as Mayo Clinic signals a promising step for medical blockchains.

Healthy Pragmatism - Key Considerations and Limitations:

While Blockchain is being hailed as a way in which we can reduce administration costs and data waste by cutting out the middleman, we still have a long way to go before this value is widely understood and healthcare players are willing to meaningfully engage.

Key limitations that must be addressed sooner rather than later include supporting regulation, business model uncertainty, and energy consumption.
In the past we had technologies that could do many aspects of what Blockchain is now offering but access and understanding is now radically different.

We must also bare in mind that the likes of trying to make a supply chain ‘better’ depends on whose version of better that is and how it is translated - blockchain itself cannot and will not make these decisions for us.

Barriers to adoption of blockchain in healthcare

Even the most promising technology is useless if the key stakeholders such as hospitals and patients do not understand and trust the intervention, with this in mind collaboration and education is crucial but we are in an era that is on our side.

Novel technologies, particularly in healthcare, are oftentimes held to an unrealistically high standard from the outset. Instead of falling into the rabbit hole of expectations and disappointment let's look at blockchain in the context of existing processes and explore incremental improvements.

In the future large healthcare organisations will most likely have the ability and willingness to allocate resources to build their own blockchains, but for now we might expect the greatest advancements to come from startups paving the way in this space.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
AI in Healthcare
AI in Healthcare
AI in Healthcare
AI in Healthcare

Masterclass: AI-based diagnostics - learnings from a real-world use case

21st October @ 9:00AM GMT

In this masterclass, Zachary Tan (Advisor at CancerAid; Venture Creation Partner at Aegis Ventures; more info here) & Lisa Zhu (Research Fellow of the Center for Eye Research Australia) will walk us through the key learnings from their latest article in Scientific Reports (Nature) on real-world AI-based screening for diabetic retinopathy in Australia. This early-stage study is one of the first globally to describe the real-world implementation of AI in healthcare.

Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Digital Health in Mental Health: Commercialization Models

21st October @ 10:45AM EDT

Join us in this informal conversation where we will discuss the best commercialisation models for digital companies in the mental health space. Our 75 minute sessions are guaranteed to be filled with interesting debate and great conversation.

Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices
Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.